 Specific Metastatic Melanoma May Improve with IMO-2125, Yervoy ComboTagged Idera Pharmaceuticals, IMO-2125, Keytruda pembrolizumab, PD-1 refractory metastatic melanoma, Yervoy ipilimumab.Next:Study Finds Entrectinib Safe, Effective for Patients with Melanoma and Other Cancers 